In February the EMCDDA published its 2015 annual work programme, which sets out the objectives for the final year of the agency’s 2013–15 strategy (1) and promises to build a solid bridge between current priorities and those defined for the next three years (2016–18).
Among the new features in 2015 will be the transformation in the way in which the agency presents statistics online. Changes will include: a clearer distinction between data and analysis; improved documentation of methods; and a better web interface. This will be one of the highlights of the 2015 European Drug Report package (June), for which delivery on the web will remain a central theme.
In the course of the year, the agency will publish four in-depth reviews in its Insights series on: psychiatric comorbidities; hepatitis C treatment; wastewater analysis; and the Internet and drug markets. A review on the drug policies of large cities will also be produced, as well as a joint EMCDDA–Europol threat assessment on methamphetamine. Evidence-based decision making will continue to be supported by the recently revamped Best practice portal.